BLPH

Bellerophon Therapeutics, Inc.
BLPH

Overview Fund Activity
Delisted

BLPH was delisted on the 13th of October, 2023.

Back to rankings

23 hedge funds and large institutions have $16.7M invested in Bellerophon Therapeutics, Inc. in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
2
Increased
5
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$751K
2
VF
2
Virtu Financial
New York
$19K
3
Citadel Advisors
3
Citadel Advisors
Florida
$40K
4
Victory Capital Management
4
Victory Capital Management
Texas
$4K
5
LPL Financial
5
LPL Financial
California
$67K

Top Sellers

1
AC
1
Armistice Capital
New York
$427K
2
TI
2
Telemetry Investments
New York
$163K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$536K
4
BlackRock
4
BlackRock
New York
$0
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
GCM
26
Gables Capital Management
Florida
– -$1K -93 Closed
1
2